30 results on '"Bicudo, Edison"'
Search Results
2. chapterSix Final Words
3. chapterThree ( Writing Code: Software Development and Communication ) {
4. chapterTwo ( Sharing Code: Social Mediations in Software Development ) {
5. chapterFour ( Owning Code: Institutional Aspects of Software Development ) {
6. Cognitive Foundations of Society: The Concept of Schemata in Cell, Gene, and Tissue Therapies
7. Sociotechnical alignment in biomedicine: The 3D bioprinting market beyond technology convergence
8. Advanced therapies and the Brexit process: emerging geographies of legal responsibilities and market opportunities.
9. Neuroimaging, Software, and Communication
10. ‘Big data’ or ‘big knowledge’? Brazilian genomics and the process of academic marketization
11. Advanced therapies, hospital exemptions & marketing authorizations: the UK’s emerging regulatory framework for point-of-care manufacture
12. Genomics Politics through Space and Time : The Case of Bioinformatics in Brazil
13. Institutional and infrastructure challenges for hospitals producing advanced therapies in the UK: the concept of ‘point-of-care manufacturing readiness’
14. Report from the 'Governing Biomodification' (BioGov) End of Project workshop July 2022
15. Patent power in biomedical innovation: Technology governance in biomodifying technologies
16. Biomodifying the ‘Natural’: from adaptive regulation to adaptive societal governance
17. Pharmaceutical Research, Democracy and Conspiracy
18. “Geographical randomization” and “Social exploitation” in clinical research: World trials in Santiago, Chile
19. The UK’s emerging regulatory framework for point-of-care manufacture: insights from a workshop on advanced therapies
20. Digital readiness in 3D bioprinting: software, governance and hospitals’ proto-clinical interfaces
21. Psicoesfera e medicina: meio construido urbano e congressos medicos na America Latina
22. Software, risks, and liabilities: ongoing and emergent issues in 3D bioprinting
23. Patents and the experimental space: social, legal and geographical dimensions of 3D bioprinting
24. Software, risks, and liabilities: ongoing and emergent issues in 3D bioprinting.
25. Patents and the experimental space: social, legal and geographical dimensions of 3D bioprinting.
26. Biomodifying technologies and experimental space: organisational and regulatory implications for the translation and valuation of health research. - ESRC
27. ‘Big data’ or ‘big knowledge’? Brazilian genomics and the process of academic marketization
28. The Active Role of Geography: A Manifesto
29. Psicoesfera e medicina: Meio construído urbano e congressos médicos na América Latina
30. Report from the MHRA Patient Forum on Biomodifying Technologies January 2020
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.